« Back to Record
Postema, P. P., Schwartz, P. P., Arbelo, E., Bannenberg, W. W., Behr, E. R., Belhassen, B., Brugada, J., Brugada, P., Camm, A. J., Casado Arroyo, R., Hoen, E., Hollak, C. C., Kaab, S., Lambiase, P. P., Leenhardt, A., Priori, S. S., Probst, V., Stunnenberg, B. B., Tfelt-Hansen, J., Van Engelen, B. G. M., Veltmann, C., Viskin, S., & Wilde, A. A. M. (2020). Continuedmisuse of orphan drug legislation: A life-threatening risk for mexiletine: orphan drug legislation. European heart journal, 41(5), 614-617. doi:10.1093/eurheartj/ehaa041
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/304985



